ROBERT WEISS: Open Payments
NPI 1235866401 · OAKLAND PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,425 in 92 payments from 14 companies in 2025. Trend: 2023 $793 · 2024 $1,561 · 2025 $2,425
Food & beverage: $2,425
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 19 | $460 |
| ABBVIE INC. | 17 | $367 |
| Neurocrine BioSciences, Inc. | 7 | $304 |
| Otsuka America Pharmaceutical, Inc. | 10 | $241 |
| Teva Pharmaceuticals USA, Inc. | 8 | $223 |
| Indivior Inc. | 4 | $211 |
| Lundbeck LLC | 9 | $192 |
| Vanda Pharmaceuticals Inc. | 6 | $166 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, INGREZZA, SUBLOCADE, AUSTEDO XR, HETLIOZ, SPRAVATO.
Industry payments across FL — which companies pay providers there.
